CHINA ORIENT ASSET MANAGEMENT (INTERNATIONAL) HOLDING
Headquartered in Hong Kong, China Orient Asset Management (International) Holding Limited (COAMCI), a wholly-owned subsidiary of China Orient Asset Management Co., Ltd. (COAMC), which founded in 2002 and subsequently restructured and renamed in June 2011. COAMCI is one of the Group’s primary overseas platform focusing on investment, asset management etc, as a bridge between domestic resources and overseas markets, delivering a specialized, diversified and comprehensive range of financial services solution. Fully utilizing the company’s multi-market and multi-currency capabilities to its advantage. With the deep understanding of the Chinese market and the benefit of investment acumen in global markets, COAMCI has kept steady growth in asset value.
CHINA ORIENT ASSET MANAGEMENT (INTERNATIONAL) HOLDING
Social Links:
Industry:
Asset Management Finance Financial Services
Founded:
1999-10-27
Status:
Active
Contact:
(852) 3987 2808
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon Domain Not Resolving Mobile Non Scaleable Content Euro IIS 8 Smart App Banner
Similar Organizations
BHM Capital
BHM Capital is a fintech that provides financial services and investment instruments including prime brokerage and investment management.
TransAsia Private Capital
TransAsia Private Capital is an investment and asset management firm.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-12-30 | Jiumaojiu | China Orient Asset Management (International) Holding investment in Venture Round - Jiumaojiu | 55 M USD |
| 2018-01-12 | Suzhou Kintor Pharmaceuticals | China Orient Asset Management (International) Holding investment in Series C - Suzhou Kintor Pharmaceuticals | 44 M USD |
| 2017-05-12 | Yixin Capital | China Orient Asset Management (International) Holding investment in Funding Round - Yixin Capital | 4 B CNY |
| 2017-03-21 | Angiotech Pharmaceuticals | China Orient Asset Management (International) Holding investment in Venture Round - Angiotech Pharmaceuticals | N/A |
| 2000-11-08 | FreeBorders | China Orient Asset Management (International) Holding investment in Series B - FreeBorders | 25 M USD |